Abstract:Proteins are involved in multiple biological functions. High-throughput technologies have allowed the measurement of thousands of proteins in population biobanks. In this study, we aimed to identify proteins related to Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) using large-scale genetic and proteomic data. We performed a two-sample Mendelian randomization (MR) study by selecting instrumental variables for the abundance of over 2,700 proteins measured by either Olink or SomaScan platforms in plasma from UK Biobank and the deCODE Health Study. We also used the latest publicly-available GWAS for the diseases of interest. The potentially causal effect of proteins on neurodegenerative diseases was estimated based on the Wald ratio. We tested 10,244 protein–disease associations, identifying 122 associations which were statistically significant (5% false discovery rate). Out of 57 associations (58%) tested using an instrumental variable from both Olink and SomaScan platforms, 33 (58%) were statistically significant in both platforms. Evidence of co-localisation between plasma protein abundance and disease risk (posterior probability >0.80) was identified for 46 protein-disease pairs. Twenty-three out of 46 protein–disease associations correspond to genetic loci not previously reported by genome-wide association studies. The newly-associated proteins for AD are involved in complement ( , ), microglia ( , ) and lysosomal functions ( ). A protein newly-associated with PD ( ) is involved in the interleukin-6 pathway, two proteins for ALS ( , ) are involved in lysosomal and astrocyte function, respectively, and proteins associated with MS are involved in blood–brain barrier function ( , ), the oligodendrocyte function ( ), the structure of the node of Ranvier and function of dorsal root ganglion ( , , ), and the response to viral infections including Epstein-Barr virus ( , ). Our study demonstrates how harnessing large-scale genomic and proteomic data can yield novel insights into the role of plasma proteome in the pathogenesis of neurodegenerative diseases.

Protein-protein Interaction Network with Machine Learning Models and Multiomics Data Reveal Potential Neurodegenerative Disease-Related Proteins

Network Integration and Protein Structural Binding Analysis of Neurodegeneration-Related Interactome.

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Deep Learning Frameworks for Protein–protein Interaction Prediction

PMINR: Pointwise Mutual Information-Based Network Regression – with Application to Studies of Lung Cancer and Alzheimer’s Disease

Protein Interaction Network Biology in Neuroscience

Predicting disease-related genes by path-based similarity and community structure in protein-protein interaction network

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

An Integrated Genetics Approach for Identifying Protein Signal Pathways of Alzheimer's Disease

Prediction Of Protein-Protein Interactions Using Subcellular And Functional Localizations

Leveraging protein-protein interactions in phenotype prediction through graph neural networks

Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?

An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease

A multi-source molecular network representation model for protein–protein interactions prediction

Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer’s disease

Network Medicine Approach Unravels Endophenotype Signature in Alzheimer's Disease through Large-Scale Comparative Proteomics Analysis: Vascular Dysfunction as a Prime Example

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways

Prediction of Deleterious Non-Synonymous SNPs Based on Protein Interaction Network and Hybrid Properties

Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease

A Mendelian randomization study identifies proteins involved in neurodegenerative diseases